Bath & Body Works, Inc. $BBWI Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 57.7% in the 4th quarter, HoldingsChannel reports. The firm owned 312,258 shares of the company’s stock after selling 426,002 shares during the quarter. Hsbc Holdings PLC’s holdings in Bath & Body Works were worth $6,333,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the 4th quarter worth approximately $31,000. Activest Wealth Management acquired a new stake in Bath & Body Works during the 4th quarter worth approximately $32,000. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after buying an additional 801 shares during the period. Parallel Advisors LLC boosted its position in Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Bath & Body Works in the third quarter worth $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Price Performance

NYSE:BBWI opened at $19.41 on Thursday. The firm has a market capitalization of $3.91 billion, a PE ratio of 5.45, a price-to-earnings-growth ratio of 2.04 and a beta of 1.38. The business’s fifty day moving average price is $19.46 and its 200 day moving average price is $20.41. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $33.96.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.Bath & Body Works’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend was Friday, June 5th. Bath & Body Works’s dividend payout ratio (DPR) is 22.47%.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. The Goldman Sachs Group lowered Bath & Body Works from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $23.00 to $19.00 in a research report on Wednesday. Wells Fargo & Company boosted their target price on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. Barclays cut their price target on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a report on Thursday, May 28th. Raymond James Financial reaffirmed a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, May 27th. Finally, Piper Sandler started coverage on Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective for the company. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.